Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
Filter
Medientyp
Sprache
Region
Bibliothek
Erscheinungszeitraum
Schlagwörter
  • 1
    Online-Ressource
    Online-Ressource
    Chichester, England :Wiley-Blackwell, | [Silver Spring, Md.] :Department of Health and Human Services, FDA, Office of Women's Health,
    UID:
    almafu_9961085833502883
    Umfang: 1 online resource (290 p.)
    Ausgabe: 1st ed.
    ISBN: 9781118316313 , 1118316312 , 9781118316290 , 1118316290 , 9781118316320 , 1118316320
    Originaltitel: Osteoporosis (2013)
    Inhalt: Osteoporosis is a growing major public health problem that impacts many women and men. In the US alone, it is estimated that 10 million Americans have osteoporosis and another 34 million have low bone mass. Both of these conditions put patients at increased risk for fracture. This book takes a ""generalist"" approach to the challenge of osteoporosis. It is aimed at those specialists, in particular gynecologists, who have regular clinical contact with particularly prone populations, such as menopausal and post menopausal women, who do not have the need for in-depth knowledge of the subject.
    Anmerkung: Description based upon print version of record. , Osteoporosis; Contents; List of Contributors; Preface; Chapter 1 Epidemiology and Genetics of Postmenopausal Osteoporosis; Introduction; Genetics; Heritability estimates in osteoporosis; Genetic studies in osteoporosis; Genes involved in osteoporosis; Early life, gene-environment interactions and epigenetics; Environmental influences in childhood; Fracture epidemiology; Geography; Secular trends; Conclusion; Acknowledgements; References; Chapter 2 Osteoporosis in Men; Introduction; Epidemiology; Classification and pathophysiology; Diagnosis and evaluation of men at risk for osteoporosis , Treatment of men with osteoporosisReferences; Chapter 3 Mechanisms of Bone Remodeling; Introduction; The bone remodeling cycle; Osteoclast differentiation; Osteoblast differentiation; Coupling between resorption and formation; The bone remodeling compartment; Bone remodeling in osteoporosis; Changes in bone remodeling during menopause; Age dependent bone loss; Bone remodeling in secondary osteoporosis; Conclusion; References; Chapter 4 Fracture Risk Assessment; Fracture risk assessment; Estimating the fracture risk based on BMD; Bone geometry and fracture risk; Age and fracture risk , Bone turnover and fracture riskOther factors and fracture risk; The FRAX® tool; FRAX can be used to make management decisions; FRAX cannot be used for following up patients; Response to risk factors is dichotomized; FRAX® uses BMD of the femoral neck; Several risk factors increasing the risk of fractures are not included in FRAX®; FRAX® can be calculated without BMD; FRAX® is a work in evolution; The Garvan Fracture Risk Calculator (FRC); Conclusion; Disclosures; Acknowledgements; References; Chapter 5 Secondary Causes of Osteoporosis: Bone Diseases; Introduction; Pathophysiology , Endocrine diseasesGastrointestinal diseases; Bariatric surgery; Hematological and immunological diseases; Myeloma bone disease and monoclonal gammopathy of undetermined significance; HIV disease and Highly Active Antiretroviral Therapy (HAART); Gaucher disease; Diagnosis; Management of secondary osteoporosis; Treatment of the underlying disease; General measures; Specific osteoporosis treatment; Conclusion; Disclosure; Acknowledgements; References; Chapter 6 Glucocorticoid-induced Osteoporosis; Introduction; Epidemiology; FRAX; Workup; Pathophysiology; Treatment , Treatment with oral bisphosphonatesTreatment with other agents; Treatment with intravenous bisphosphonates; Treatment with bone formation agents; Guidelines for managing GIO; IOF guidelines; References; Chapter 7 Secondary Causes of Osteoporosis: Other Medications; Introduction; Aromatase inhibitors; Antidepressants; Anti-epileptic drugs; Calcineurin inhibitors; Depot medroxyprogesterone acetate; GnRH agonists; Proton pump inhibitors; Thiazolidinediones; Summary; References; Chapter 8 Hormone Therapy for Osteoporosis; Inroduction; Mechanism of action; The effect of estrogen therapy on bone , Changes in bone mineral density , English
    Weitere Ausg.: ISBN 9781119968917
    Weitere Ausg.: ISBN 1119968917
    Weitere Ausg.: ISBN 9781299743267
    Weitere Ausg.: ISBN 1299743269
    Sprache: Englisch
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    Online-Ressource
    Online-Ressource
    Chichester, England :Wiley-Blackwell,
    UID:
    almahu_9948318715002882
    Umfang: 1 online resource (ix, 278 p.) : , ill. (some col.)
    Ausgabe: Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
    Sprache: Englisch
    Schlagwort(e): Electronic books.
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 3
    Online-Ressource
    Online-Ressource
    Chichester, England :Wiley-Blackwell,
    UID:
    almahu_9948198038602882
    Umfang: 1 online resource (ix, 278 pages) : , illustrations (some color)
    ISBN: 9781118316290 , 1118316290 , 9781118316320 , 1118316320 , 9781299743267 , 1299743269 , 1118316312 , 9781118316313
    Inhalt: Osteoporosis is a growing major public health problem that impacts many women and men. In the US alone, it is estimated that 10 million Americans have osteoporosis and another 34 million have low bone mass. Both of these conditions put patients at increased risk for fracture. This book takes a "generalist" approach to the challenge of osteoporosis. It is aimed at those specialists, in particular gynecologists, who have regular clinical contact with particularly prone populations, such as menopausal and post menopausal women, who do not have the need for in-depth knowledge of the subject.
    Anmerkung: Epidemiology and Genetics of Postmenopausal Osteoporosis -- Osteoporosis in Men -- Mechanisms of Bone Remodeling -- Fracture Risk Assessment -- Secondary Causes of Osteoporosis: bone diseases -- Glucocorticoid-induced Osteoporosis -- Secondary Causes of Osteoporosis: Other Medications -- Hormone Therapy for Osteoporosis -- Bisphosphonates -- Denosumab -- Parathyroid Hormone: Anabolic Treatment of Osteoporosis -- Optimum Calcium and Vitamin D for the Prevention and Treatment of Osteoporosis -- The Use of Combination Therapy in the Treatment of Postmenopausal Osteoporosis -- Emerging Therapies -- Monitoring Therapy for Osteoporosis -- Persistence and Compliance with Medications to Prevent Fractures: Epidemiology, Etiology, and Management Issues.
    Weitere Ausg.: Print version: Osteoporosis. Chichester, West Sussex, UK ; Hoboken, NJ : Wiley Blackwell, 2013 ISBN 9781119968917
    Sprache: Englisch
    Schlagwort(e): Electronic books.
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Meinten Sie 9781108416320?
Meinten Sie 9781118176320?
Meinten Sie 9781118116340?
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie auf den KOBV Seiten zum Datenschutz